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Escherichia coli resistant to quinolones in a neonatal unit Multiple publications have focused on the microbiological and clinical aspects of infections caused by quinolone-resistant E. coli in adults (Boyd et al., 2008) , but there is little information related to paediatric patients (particularly neonates) as quinolones are not usually recommended for these patients (Van den Oever et al., 1998) .
A relationship between antimicrobial, resistance, virulence and phylogenetic group in E. coli has been reported (Horcajada et al., 2005) . Isolates of the two phylogenetic groups more often isolated from invasive infections (B2 and D) usually contain more virulence factors than those of groups A or B1, which are frequently isolated as commensal isolates (Escobar-Páramo et al., 2004) . However, E. coli strains resistant to quinolones commonly present less virulence factors than quinolone-susceptible isolates (Horcajada et al., 2005) . Again, there is limited information on this relationship when considering neonates.
Quinolones, cotrimoxazole and tetracyclines are not used in the neonatal unit of our hospital (University Hospital Marqués de Valdecilla). Unexpectedly, quinolone-, trimethoprim/ sulfamethoxazole-and tetracyclineresistant clinical isolates of E. coli were cultured from some of the admitted neonates. The objectives of this work were to describe the clonal relationship, the phylogenetic group, the mechanisms of resistance to quinolones and the presence of genes coding for virulence factors in these isolates. The clonal relationship of the isolates was determined by Rep-PCR (repetitive extragenic palindromic PCR) (Vila et al., 1996) . Two isolates were considered clonally unrelated when two or more different bands were observed (Cano et al., 2009) . Determination of phylogenetic groups was performed by multiplex PCR (Clermont et al., 2000) . Changes in the quinolone-resistancedetermining region of the gyrA and parC genes were studied by PCR amplification and sequencing (Cano et al., 2009) None of the isolates contained plasmid-encoded quinoloneresistance genes qnrA, qnrB, qnrS, qepA and aac(6')-Ib-cr when these genes were tested by multiplex PCR (Cano et al., 2009) .
Large plasmids around 100-150 kb were extracted by the Kado and Liu method (Kado & Liu, 1981) and characterized by replicon typing (Carattoli et al., 2005 susceptibility to quinolones nor contained any of the studied plasmid-encoded quinolone-resistance genes. Transconjugants from the same clonal group presented a similar resistance phenotype and plasmid content: those from Rep-PCR pattern I (selected with ampicillin) were resistant to ampicillin and contained an IncF (FIB replicon) plasmid; those from pattern II (selected with all three antimicrobial agents used) were resistant to ampicillin, gentamicin, sulfamethoxazole and tetracycline, and contained IncF (replicons FIA, FIB, FII) plasmids; and those from pattern III (selected with ampicillin or gentamicin) were resistant to ampicillin and gentamicin, and contained plasmids of IncF (FIB replicon), IncN and IncI1.
Virulence factors encoded by genes hlyA, sfaS, focG, fimH, bma, gaf, afa/dra, cnf1, iutA, fyuA, traT, sfa/foc operon, ibeA, PAI, kpsMTII, kpsMTIII, KpsMTK1 and KpsMTK5, were determined by PCR, as described elsewhere (Johnson & Stell, 2000) . Detection of iroN was carried out by PCR using primers IroN-F, 59-GAAAGCTCTGG-TGGACGGTA-39, and IroN-R, 59-CGACA-GAGGATTACCGGTGT-39. None of the isolates were haemolytic on sheep blood agar nor contained the hlyA gene. All isolates studied contained the genes for virulence determinants iutA and fimH. In two out of three isolates of clonal group I studied the ibeA gene was also detected. All isolates belonging to Rep-PCR pattern II were positive for fyuA, PAI, kpsMTII and kpsMTK5, and two of them also had the traT gene. In all four isolates of clonal group III studied, traT, iroN and fyuA were detected (Table 1) .
In this study we have characterized multiresistant ESBL-negative E. coli from patients admitted to our neonatal unit, where quinolones, trimethoprim/ sulfamethoxazole and tetracyclines are not used. Quinolones-resistance rates are usually lower in children than in adults (Boyd et al., 2008) .
Quinolone resistance in E. coli is a multifactorial process. Single mutations in gyrA cause resistance to nalidixic acid and a moderate decrease in the activity of fluoroquinolones . Additional mutations in this gene or in parC cause stepwise increases in the level of resistance, as observed in our isolates with Rep-PCR patterns III (with one mutation in gyrA and another one in parC), which were either susceptible (two isolates) or intermediately susceptible (three isolates) to fluoroquinolones. Clinically relevant resistance to fluoroquinolones (as defined by the CLSI) is reached when 3-4 mutations have been selected in gyrA/parC (Calva et al., 1996) , just as observed in organisms with Rep-PCR patterns I and II.
Resistance to aminoglycosides has been well documented in enterobacteria isolated from newborns (Van der Zwet et al., 1999) . The genes involved are usually encoded on conjugative plasmids also containing genes responsible for trimethoprim/ sulfamethoxazole and tetracycline resistance. In the isolates we studied, resistance to these agents was determined by conjugative plasmids of incompatibility groups IncF, IncN and/or IncI1, usually related to antimicrobial resistance in enterobacteria (Carattoli, 2009 ).
Most reports indicate that quinoloneresistant E. coli are usually of phylogenetic group D or A (Johnson & Stell, 2000) . This agrees with our isolates of clonal groups I and III, both included in group D. In addition, the isolates of pattern II corresponded to group B2. Isolates of clonal group II/phylogenetic group B2 contained a higher number of virulence determinant genes than those of the other two clonal groups of phylogenetic group D, a situation also in agreement with previous studies.
Clonal analysis showed that the 18 isolates were obtained in 3 separated periods. This multiclonality suggests that the introduction of the resistant organisms in the unit occurred independently on every occasion. Two clusters persisted for just 1 or 2 months, but another one lasted for 7 months. Other authors have also demonstrated, using molecular methods, the existence of several clusters (with a small to large number of patients affected) of multiresistant organisms within the same neonatal unit (De Oliveira Garcia et al., 2008) .
Quinolones are not used in our unit and, therefore, they cannot be blamed as the selecting agents of the multiresistant isolates. We may speculate that the indicated chromosomal mutations have been selected elsewhere and that the newborns have acquired the resistant organisms either directly or indirectly from an external source: their mother or other relatives who may have been in contact with them, health workers or other previously colonized or infected newborns. Unfortunately, the retrospective nature of this study precludes a more precise definition of these possibilities. As the isolates were also resistant to ampicillin and resistant or of intermediate sensitivity to tobramycin, and the newborns were empirically treated with a combination of these agents, it is also possible that these compounds may have favoured the colonization and persistence of these resistant organisms.
